Hansenula anomala: a new fungal pathogen. Two case reports and a review of the literature

Related Experiment Videos

A S Klein1, G T Tortora, R Malowitz

  • 1Department of Medicine, School of Allied Health Professions, State University of New York, Stony Brook 11794-8153.

Insights

Noncandidal yeast infections, like Hansenula anomala fungemia, are increasing in immunocompromised patients, often linked to central venous catheters. Prompt treatment with amphotericin B and catheter removal is effective.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Fungal infections are a significant concern in immunocompromised individuals.
  • Noncandidal yeasts are an emerging cause of fungemia.
  • Central venous catheters are recognized risk factors for fungal infections.

Observation:

  • Two patients with gynecologic cancers developed Hansenula anomala fungemia post-central venous catheter insertion.
  • Both patients had prolonged catheter use and frequent manipulation.
  • Literature review identified 19 additional cases of H. anomala fungemia over four decades, with a recent increase.

Findings:

  • Hansenula anomala fungemia is associated with underlying diseases and central venous catheter use.
  • A recent surge in reported cases suggests increased incidence or recognition.
  • All H. anomala isolates tested were susceptible to amphotericin B.

Implications:

  • Hansenula anomala should be considered an opportunistic pathogen in at-risk populations.
  • Catheter management is crucial in preventing and treating fungemia.
  • Amphotericin B and catheter removal represent an effective treatment strategy.

Related Concept Videos